Steminent Biotherapeutics (ROCO:7729) Days Inventory : 503.53 (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Steminent Biotherapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Steminent Biotherapeutics's Average Total Inventories for the six months ended in Jun. 2024 was NT$10.50 Mil. Steminent Biotherapeutics's Cost of Goods Sold for the six months ended in Jun. 2024 was NT$3.80 Mil. Hence, Steminent Biotherapeutics's Days Inventory for the six months ended in Jun. 2024 was 503.53.

The historical rank and industry rank for Steminent Biotherapeutics's Days Inventory or its related term are showing as below:

ROCO:7729' s Days Inventory Range Over the Past 10 Years
Min: 168.69 Med: 628.17 Max: 1028.72
Current: 680.43

During the past 4 years, Steminent Biotherapeutics's highest Days Inventory was 1028.72. The lowest was 168.69. And the median was 628.17.

ROCO:7729's Days Inventory is ranked worse than
86.47% of 643 companies
in the Biotechnology industry
Industry Median: 188.02 vs ROCO:7729: 680.43

Steminent Biotherapeutics's Days Inventory declined from Jun. 2023 (960.66) to Jun. 2024 (503.53).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Steminent Biotherapeutics's Inventory Turnover for the six months ended in Jun. 2024 was 0.36.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Steminent Biotherapeutics Days Inventory Historical Data

The historical data trend for Steminent Biotherapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steminent Biotherapeutics Days Inventory Chart

Steminent Biotherapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Days Inventory

168.69

991.55

264.78

1,028.72

Steminent Biotherapeutics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Inventory	Get a 7-Day Free Trial			4,983.54	69.05	960.66	1,196.17	503.53

Competitive Comparison of Steminent Biotherapeutics's Days Inventory

For the Biotechnology subindustry, Steminent Biotherapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steminent Biotherapeutics's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Steminent Biotherapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Steminent Biotherapeutics's Days Inventory falls into.

Steminent Biotherapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Steminent Biotherapeutics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (3.475	+	7.669)	/	2 )	/	1.977	*	365
=	5.572					/	1.977	*	365
=	1,028.72

Steminent Biotherapeutics's Days Inventory for the quarter that ended in Jun. 2024 is calculated as:

	Days Inventory (Q: Jun. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2023 )	+	Total Inventories (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (7.669	+	13.322)	/	2 )	/	3.804	*	365 / 2
=	10.4955					/	3.804	*	365 / 2
=	503.53

Steminent Biotherapeutics (ROCO:7729) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Steminent Biotherapeutics's Inventory Turnover for the six months ended in Jun. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	3.804	/	10.4955
	=	0.36

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Steminent Biotherapeutics's Inventory to Revenue for the six months ended in Jun. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	10.4955	/	0
	=

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Steminent Biotherapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of Steminent Biotherapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Steminent Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445

Website

http://www.steminent.com

Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.

Steminent Biotherapeutics Headlines

No Headlines